PharmaShots

JUNE 2, 2023

Impact Therapeutics Entered into a License and Collaboration Agreement with Eikon Therapeutics to Develop and Commercialize IMP1734 Date: June 02, 2023 | Tags: Impact Therapeutics, Eikon Therapeutics, IMP1734, Pharma, China, Hong Kong, Macau, Taiwan BMS’ Mavacamten Receives the NICE Recommendation for the Treatment of Obstructive Hypertrophic (..)

FDA 40

FDA 40

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization Vaccines 52

The Checkup by Singlecare

SEPTEMBER 7, 2023

Mounjaro (tirzepaptide), manufactured by Eli Lilly Inc., Sodium-glucose co-transporter 2 (SGLT2) and dipeptidyl peptidase 4 inhibitors (DPP4i) drugs are highly effective oral diabetic treatments. Some drugs in this class are FDA-approved to aid in weight loss and management.

Insurance 52

Insurance Insurance Coverage FDA Dosage 52

PharmaShots

MARCH 9, 2023

Designation: Co-Founder and Chief Executive Officer Previous company: Thin Film Electronics ASA (4 yrs. She developed various mobile technologies and pioneered early electronic labels including NFC tags, which helped Thin Film Electronics win the Wall Street Innovation Award and the Global Technology Award.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40